clinical trial

An experimental AstraZeneca drug doubled median survival from five to 10 months in a trial involving 532 patients with advanced stomach cancer.

A pioneering study published in Nature Medicine reveals how a revolutionary double neural bypass restored both movement and sensation in a man with complete paralysis, offering new hope for spinal cord injury treatment